105 related articles for article (PubMed ID: 470184)
1. Immunochemical studies of lipids. V. Effect of modified hydrophobic moiety on immunogenicity and immunologic reactivity of Forssman glycolipid.
Uemura K; Yuzawa M; Taketomi T
Jpn J Exp Med; 1979 Feb; 49(1):1-8. PubMed ID: 470184
[TBL] [Abstract][Full Text] [Related]
2. Characterization of anti-Forssman (anti-Fs) antibodies in human sera: their specificity and possible changes in patients with cancer.
Young WW; Hakomori SI; Levine P
J Immunol; 1979 Jul; 123(1):92-6. PubMed ID: 448159
[No Abstract] [Full Text] [Related]
3. Neutral glycolipid antigens as developmental markers of mouse teratocarcinoma and early embryos: an immunologic and chemical analysis.
Willison KR; Karol RA; Suzuki A; Kundu SK; Marcus DM
J Immunol; 1982 Aug; 129(2):603-9. PubMed ID: 7045228
[TBL] [Abstract][Full Text] [Related]
4. Immunochemical determination of Forssman and blood group A-active glycolipids in human gastric mucosa by inhibition assay of liposome lysis.
Uemura K; Hattori H; Kitazawa N; Taketomi T
J Immunol Methods; 1982 Sep; 53(2):221-32. PubMed ID: 6815276
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies detecting different epitopes on the Forssman glycolipid hapten.
Sonnenberg A; van Balen P; Hengeveld T; Kolvenbag GJ; Van Hoeven RP; Hilgers J
J Immunol; 1986 Aug; 137(4):1264-9. PubMed ID: 2426359
[TBL] [Abstract][Full Text] [Related]
6. Intermolecular interaction between glycolipids and glycophorin on liposomal membranes.
Endo T; Nojima S; Inoue K
J Biochem; 1982 Dec; 92(6):1883-90. PubMed ID: 7161262
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of gangliosides on immune reactions of antibodies to neutral glycolipids in liposomes.
Shichijo S; Alving CR
Biochim Biophys Acta; 1986 Jun; 858(1):118-24. PubMed ID: 3707956
[TBL] [Abstract][Full Text] [Related]
8. A simple method to measure anti-glycolipid antibody by using complement-mediated immune lysis of fluorescent dye-trapped liposomes.
Yasuda T; Naito Y; Tsumita T; Tadakuma T
J Immunol Methods; 1981; 44(2):153-8. PubMed ID: 7024415
[TBL] [Abstract][Full Text] [Related]
9. Immunochemical relationship between Forssman and globoside glycolipid antigens.
Karol RA; Kundu SK; Marcus DM
Immunol Commun; 1981; 10(3):237-50. PubMed ID: 7037611
[TBL] [Abstract][Full Text] [Related]
10. Anti-peripheral nerve myelin antibodies in Guillain-Barre syndrome bind a neutral glycolipid of peripheral myelin and cross-react with Forssman antigen.
Koski CL; Chou DK; Jungalwala FB
J Clin Invest; 1989 Jul; 84(1):280-7. PubMed ID: 2738153
[TBL] [Abstract][Full Text] [Related]
11. Complement-dependent cytotoxic antitumor antibody. II. Quantitative determination of cell-bound immunoglobulin M1.
Boyle MD; Langone JJ
J Natl Cancer Inst; 1979 Jun; 62(6):1537-44. PubMed ID: 286124
[TBL] [Abstract][Full Text] [Related]
12. Glycolipid changes associated with oncogenesis and ontogenesis, and the inhibition of the process of transformation by monovalent anti-glycolipid antibodies.
Hakomori S
Adv Pathobiol; 1980; 7():270-81. PubMed ID: 7405743
[No Abstract] [Full Text] [Related]
13. Expression of Forssman glycolipid and blood group-related antigens A, Le(x), and Le(y) in human gastric cancer and in fetal tissues.
Uemura K; Hattori H; Ono K; Ogata H; Taketomi T
Jpn J Exp Med; 1989 Dec; 59(6):239-49. PubMed ID: 2695680
[TBL] [Abstract][Full Text] [Related]
14. Anti-Forssman antibody in human sera: properties and decreased level in cancer patients.
Kijimoto-Ochiai S; Takahashi W; Makita A
Jpn J Exp Med; 1981 Jun; 51(3):149-55. PubMed ID: 7300030
[TBL] [Abstract][Full Text] [Related]
15. Liposome agglutination and liposomal membrane immune-damage assays for the characterization of antibodies to glycosphingolipids.
Uemura K; Yuzawa-Watanabe M; Kitazawa N; Taketomi T
J Biochem; 1980 Jun; 87(6):1641-8. PubMed ID: 7190563
[TBL] [Abstract][Full Text] [Related]
16. Immunogenic properties of glycolipids of Nocardiopsis dassonvillei.
Mordarska H; Smogór W; Gamian A
Arch Immunol Ther Exp (Warsz); 1985; 33(4):523-30. PubMed ID: 4084014
[TBL] [Abstract][Full Text] [Related]
17. [Chemical modification of antibodies against carcino-embryonal antigen].
Guzov VM; Usanov SA; Rodionov MA; But'kova LS; Golubovich VP; Chashchin VL
Biokhimiia; 1989 Dec; 54(12):2010-22. PubMed ID: 2633803
[TBL] [Abstract][Full Text] [Related]
18. Polarity of the Forssman glycolipid in MDCK epithelial cells.
Nichols GE; Shiraishi T; Allietta M; Tillack TW; Young WW
Biochim Biophys Acta; 1987 Sep; 930(2):154-66. PubMed ID: 3040119
[TBL] [Abstract][Full Text] [Related]
19. Capping of exogenous Forssman glycolipid on cells.
Stern PL; Bretscher MS
J Cell Biol; 1979 Sep; 82(3):829-33. PubMed ID: 389939
[TBL] [Abstract][Full Text] [Related]
20. Identification of Forssman as a major guinea pig xenoantigen.
Cairns T; Gustavsson M; Goldberg L; Steen L; Strokan V; Samuelsson B; Taube D
Transplant Proc; 1996 Apr; 28(2):575. PubMed ID: 8623280
[No Abstract] [Full Text] [Related]
[Next] [New Search]
